Exact Mass: 391.12018560000007
Exact Mass Matches: 391.12018560000007
Found 47 metabolites which its exact mass value is equals to given mass value 391.12018560000007,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glycoperine
Glycoperine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound and an oxacycle. Glycoperine is a natural product found in Haplophyllum acutifolium and Haplophyllum latifolium with data available.
Chlorohaloperidol
Zidebactam
C13H21N5O7S (391.11616360000005)
(S)-2-((S)-2-((S)-2-Amino-4-carboxybutanamido)-4-carboxybutanamido)succinic acid
Glycoperine
Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids
PharmaGSID_47330
C21H15F2N5O (391.12446040000003)
CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8922; ORIGINAL_PRECURSOR_SCAN_NO 8921 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8944; ORIGINAL_PRECURSOR_SCAN_NO 8942 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8967; ORIGINAL_PRECURSOR_SCAN_NO 8965 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8982; ORIGINAL_PRECURSOR_SCAN_NO 8980 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8963; ORIGINAL_PRECURSOR_SCAN_NO 8961 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8988; ORIGINAL_PRECURSOR_SCAN_NO 8987
Thiazolidine, 3-[(4-butoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-
C20H22ClNO5 (391.11864320000007)
(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE
N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE
C18H21N3O5S (391.12018560000007)
Zidebactam
C13H21N5O7S (391.11616360000005)
C254 - Anti-Infective Agent > C258 - Antibiotic
tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate
C18H21N3O5S (391.12018560000007)
(5-acetamido-3,4-diacetyloxy-6-ethylsulfanyloxan-2-yl)methyl acetate
Tavapadon
C19H16F3N3O3 (391.11437020000005)
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].
Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate
Unii-gmy695BP6Q
C21H15F2N5O (391.12446040000003)
TPA-023B is a high-affinity and orally active GABAA receptor α2/α3 subtype (Kis of 0.73 nM/2 nM) partial agonist and a α1 subtype (Ki of 1.8 nM) antagonist. TPA-023B has non-sedating anxiolytic-like properties[1].
4,8-dimethoxyfuro[2,3-b]quinolin-7-yl 6-deoxy-beta-D-allopyranoside
(2R,3S,4S,5S,6R)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyloxane-3,4,5-triol
2-hydroxy-2-[(1s,10r,11r,13s)-7-hydroxy-5-methoxy-2,9-dioxo-11-propyl-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl]ethanimidic acid
2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol
n-(7-methyl-1,4-dioxo-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}naphthalen-2-yl)ethanimidic acid
n-(2-{[2-hydroxy-6-(methoxycarbonyl)phenyl]-c-hydroxycarbonimidoyl}phenyl)pyridine-3-carboximidic acid
n-{7-methyl-1,4-dioxo-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]naphthalen-2-yl}ethanimidic acid
1,2-bis({4-[(1e,3e)-4-carboxybuta-1,3-dien-1-yl]phenyl})-1-hydroxydiazenium
[C22H19N2O5]+ (391.12939040000003)
